These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34374699)

  • 1. Corrigendum to 'Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study'.
    Tian DC; Li Z; Yuan M; Zhang C; Gu H; Wang Y; Shi FD
    Lancet Reg Health West Pac; 2021 Mar; 8():100118. PubMed ID: 34374699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
    Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
    Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study.
    Tian DC; Li Z; Yuan M; Zhang C; Gu H; Wang Y; Shi FD
    Lancet Reg Health West Pac; 2020 Sep; 2():100021. PubMed ID: 34327375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of effect of empirical attack-preventive immunotherapies in neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
    Ma J; Yu H; Wang H; Zhang X; Feng K
    J Neuroimmunol; 2022 Feb; 363():577790. PubMed ID: 34959021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mediating effect of health-related hardiness on the degree of physical disability and perceived stress in Chinese female patients with neuromyelitis optica spectrum disorder.
    Xu Y; Su X; Lu X; Zhang M; Wang W; Ding D; Chao Q; Jiang H
    Mult Scler Relat Disord; 2019 Oct; 35():67-72. PubMed ID: 31351263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyelitis optica spectrum disorder in China: Quality of life and medical care experience.
    Huang W; ZhangBao J; Chang X; Wang L; Zhao C; Lu J; Wang M; Ding X; Xu Y; Zhou L; Li D; Behne MK; Behne JM; Yeaman MR; Katz E; Lu C; Quan C;
    Mult Scler Relat Disord; 2020 Nov; 46():102542. PubMed ID: 33296965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Incidence of Neuromyelitis Optica Spectrum Disorder in Korea: Population Based Study.
    Lee HL; Kim JY; Seok JM; Hong YH; Lim NG; Shin HY; Kim BJ; Hwang SY; Min JH; Kim BJ
    J Korean Med Sci; 2020 May; 35(17):e115. PubMed ID: 32356417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of neuromyelitis optica spectrum disorder in the Central Denmark Region.
    Dale GH; Svendsen KB; Gjelstrup MC; Christensen T; Houen G; Nielsen E; Bek T; Petersen T
    Acta Neurol Scand; 2018 Jun; 137(6):582-588. PubMed ID: 29359475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinical Characteristics of Primary Sjogren's Syndrome With Neuromyelitis Optica Spectrum Disorder in China: A STROBE-Compliant Article.
    Qiao L; Wang Q; Fei Y; Zhang W; Xu Y; Zhang Y; Zhao Y; Zeng X; Zhang F
    Medicine (Baltimore); 2015 Jul; 94(28):e1145. PubMed ID: 26181553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide.
    Hor JY; Asgari N; Nakashima I; Broadley SA; Leite MI; Kissani N; Jacob A; Marignier R; Weinshenker BG; Paul F; Pittock SJ; Palace J; Wingerchuk DM; Behne JM; Yeaman MR; Fujihara K
    Front Neurol; 2020; 11():501. PubMed ID: 32670177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiculopathy in neuromyelitis optica. How does anti-AQP4 Ab involve PNS?
    Kim S; Park J; Kwon BS; Park JW; Lee HJ; Choi JH; Nam K
    Mult Scler Relat Disord; 2017 Nov; 18():77-81. PubMed ID: 29141825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stressful life events, socioeconomic status, and the risk of neuromyelitis optica spectrum disorder: A population-based case-control study.
    Rafiee F; Tarjoman T; Moghadasi AN; Sahraian MA; Azimi A; Rezaeimanesh N; Eskandarieh S
    Mult Scler Relat Disord; 2020 Nov; 46():102544. PubMed ID: 33032056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis Optica Spectrum Disorder: Clinical Burden and Cost of Relapses and Disease-Related Care in US Clinical Practice.
    Royston M; Kielhorn A; Weycker D; Shaff M; Houde L; Tanvir I; Bhattacharyya S; Levy M
    Neurol Ther; 2021 Dec; 10(2):767-783. PubMed ID: 34046846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BLK polymorphisms and expression level in neuromyelitis optica spectrum disorder.
    Yin BW; Li B; Mehmood A; Yuan C; Song S; Guo RY; Zhang L; Ma T; Guo L
    CNS Neurosci Ther; 2021 Dec; 27(12):1549-1560. PubMed ID: 34637583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review.
    Shahmohammadi S; Doosti R; Shahmohammadi A; Mohammadianinejad SE; Sahraian MA; Azimi AR; Harirchian MH; Asgari N; Naser Moghadasi A
    Mult Scler Relat Disord; 2019 Jan; 27():350-363. PubMed ID: 30476871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia.
    Stastna D; Menkyova I; Drahota J; Mazouchova A; Adamkova J; Ampapa R; Grunermelova M; Peterka M; Recmanova E; Rockova P; Rous M; Stetkarova I; Valis M; Vachova M; Woznicova I; Horakova D
    Mult Scler Relat Disord; 2021 Sep; 54():103104. PubMed ID: 34216998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-COVID Neuromyelitis Optica Spectrum Disorder.
    Rafique S; Wasim A; Sultan T; Ahmad A
    J Coll Physicians Surg Pak; 2021 Jul; 31(7):138-140. PubMed ID: 34271816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Müller cells and retinal axons can be primary targets in experimental neuromyelitis optica spectrum disorder.
    Zeka B; Lassmann H; Bradl M
    Clin Exp Neuroimmunol; 2017 Jan; 8(Suppl Suppl 1):3-7. PubMed ID: 28344667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of neuromyelitis optica spectrum disorder in Belo Horizonte, Southeast Brazil.
    Lana-Peixoto MA; Talim NC; Pedrosa D; Macedo JM; Santiago-Amaral J
    Mult Scler Relat Disord; 2021 May; 50():102807. PubMed ID: 33609926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary.
    Papp V; Iljicsov A; Rajda C; Magyari M; Koch-Henriksen N; Petersen T; Jakab G; Deme I; Nagy F; Imre P; Lohner Z; Kovács K; Birkás AJ; Köves Á; Rum G; Nagy Z; Kerényi L; Vécsei L; Bencsik K; Jobbágy Z; Diószeghy P; Horváth L; Galántai G; Kasza J; Molnár G; Simó M; Sátori M; Rózsa C; Ács P; Berki T; Lovas G; Komoly S; Illes Z
    Eur J Neurol; 2020 Feb; 27(2):308-317. PubMed ID: 31465603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.